Section Arrow
Quote
TLSA.NASDAQ
- Tiziana Life Sciences Ltd
Quotes are at least 15-min delayed:2026/02/19 19:18 EST
After Hours
Last
 1.4187
+0.0187 (+1.34%)
Bid
1.38
Ask
1.42
High 1.42 
Low 1.3834 
Volume 318 
Regular Hours (Closed)
Last
 1.4
0 (0.00%)
Day High 
1.4 
Prev. Close
1.4 
1-M High
1.77 
Volume 
65.24K 
Bid
1.38
Ask
1.42
Day Low
1.34 
Open
1.38 
1-M Low
1.25 
Market Cap 
178.15M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.38 
20-SMA 1.49 
50-SMA 1.53 
52-W High 2.6 
52-W Low 0.73005 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.12/-0.09
Enterprise Value
178.15M
Balance Sheet
Book Value Per Share
0.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.1967+0.0047+2.45%0.09PE
After Hours 0.1892 -0.0075 -3.81%
IBRXImmunityBio8.61+0.07+0.82%-- 
After Hours 8.5 -0.11 -1.28%
DRMADermata Therapeutics Inc1.93+0.65+50.78%0.08PE
After Hours 1.8099 -0.1201 -6.22%
QNCXQuince Therapeutics0.1622-0.0158-8.88%-- 
After Hours 0.163 +0.0008 +0.49%
LIMNLiminatus Pharma Inc0.2383-0.0066-2.69%-- 
After Hours 0.237 -0.0013 -0.55%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.